Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease rheumatoid arthritis
Symptom C0007222|cardiovascular disease
Sentences 60
PubMedID- 22360682 Lack of association between tlr4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 25011482 Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 23244227 cardiovascular diseases in patients with rheumatoid arthritis.
PubMedID- 20868308 Objectives: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd).
PubMedID- 22337612 Apolipoprotein b-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 24498229 In observational studies the finding of incident cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids is strongly confounded by indication due to high disease activity.
PubMedID- 24585741 Objective: despite numerous studies reporting increased cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra), the impact of ra on managing modifiable cvd risk factors remains understudied.
PubMedID- 23749610 Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study.
PubMedID- 23983474 The effects of the il-6r and il-6st/gp130 genes on the risk for cardiovascular disease in patients with rheumatoid arthritis were assessed in patients with rheumatoid arthritis who were genotyped for the functional gene polymorphisms.
PubMedID- 23666917 Objective: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd), but little is known about its association with another form of vascular disorder, venous thromboembolism (vte).
PubMedID- 21385539 Lack of association between lep rs2167270 (19 g>a) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 25026799 cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy.
PubMedID- 24458537 The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients.
PubMedID- 22337246 Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 21109513 cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives.
PubMedID- 21180241 Platelet histogram indices and cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 21269581 Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 23204310 Atherosclerosis and cardiovascular disease in rheumatoid arthritis.
PubMedID- 20638217 Objective: this paper describes the rationale and design of a theory-informed patient education programme addressing cardiovascular disease for people with rheumatoid arthritis (ra) to illustrate how theory can explicitly be translated into practice.
PubMedID- 24511540 Suggests that vegfa polymorphisms do not seem to exert a significant influence on the risk of cardiovascular disease in patients with rheumatoid arthritis 6.
PubMedID- 20735865 Palomino-morales and colleagues 1 report the novel observation that a common polymorphism in the gene for methylene tetrahydrofolate reductase (mthfr) that markedly reduces enzyme activity (by as much as 65% in homozygotes) may predispose to the development of atherosclerotic cardiovascular disease (ascvd) in patients with rheumatoid arthritis (ra).
PubMedID- 20164773 cardiovascular disease in rheumatoid arthritis: a step forward.
PubMedID- 26117596 Prevention of cardiovascular disease in rheumatoid arthritis.
PubMedID- 24795506 Lack of association between abo, ppap2b, adamst7, pik3cg, and ednra and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 25754335 rheumatoid arthritis (ra) associates with increased cardiovascular disease (cvd) mortality thought to be due to accelerated arterial disease.
PubMedID- 22249350 Risk factors for cardiovascular disease in rheumatoid arthritis.
PubMedID- 22927710 Genetic markers of cardiovascular disease in rheumatoid arthritis.
PubMedID- 21420089 Tnfa -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 20827876 cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions.
PubMedID- 20383550 Atherosclerosis plays a key role in cardiovascular disease in patients with rheumatoid arthritis (ra).
PubMedID- 24874661 Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis.
PubMedID- 23256829 Traditional cardiovascular risk factors only partly explain increased risk of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 21411091 Prediction of genetic risk for cardiovascular disease in patients with rheumatoid arthritis: present and promises.
PubMedID- 22284683 We also suggest strategies for risk stratification and treatment of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 21388351 Vascular endothelial growth factor a and cardiovascular disease in rheumatoid arthritis patients.
PubMedID- 21276397 Excess mortality from cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 23584985 Novel risk factors for cardiovascular disease in rheumatoid arthritis.
PubMedID- 22521305 Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 23818136 Objective: to determine whether the impact of aging on cardiovascular disease (cvd) risk in patients with rheumatoid arthritis (ra) differs from that in the general population (as estimated by the framingham risk score frs).
PubMedID- 22935383 Objectives: the impact of metabolic risk factors on atherosclerotic cardiovascular disease (acvd) in patients with rheumatoid arthritis (ra) from developing populations is currently unknown.
PubMedID- 22513132 The excess risk of cardiovascular disease (cvd) associated with rheumatoid arthritis (ra) has long been recognized .
PubMedID- 21520672 Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--nsaid a possible cause.
PubMedID- 21073447 To assess the potential association between adipoq rs266729 and rs1501299 gene polymorphisms, either isolated or in combination, and cardiovascular disease in patients with rheumatoid arthritis (ra), 674 patients seen at the rheumatology outpatient clinics of hospital xeral-calde, lugo, and hospital san carlos, madrid, spain, were analyzed.
PubMedID- 21846359 Ccr5delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study.
PubMedID- 20952464 Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease.
PubMedID- 23300117 Objectives: to assess the effect of golimumab, with or without methotrexate (mtx), on serum lipids and inflammatory markers of cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra) in two phase 3, randomised, placebo-controlled trials (go-before and go-forward).
PubMedID- 23193471 cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america.
PubMedID- 24498997 Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis.
PubMedID- 24268008 cardiovascular disease in rheumatoid arthritis.
PubMedID- 26082375 Pathophysiologic mechanisms and risk management of cardiovascular disease in patients with rheumatoid arthritis.

Page: 1 2